JP2022546597A5 - - Google Patents
Info
- Publication number
- JP2022546597A5 JP2022546597A5 JP2022514708A JP2022514708A JP2022546597A5 JP 2022546597 A5 JP2022546597 A5 JP 2022546597A5 JP 2022514708 A JP2022514708 A JP 2022514708A JP 2022514708 A JP2022514708 A JP 2022514708A JP 2022546597 A5 JP2022546597 A5 JP 2022546597A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- item
- itr
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962896980P | 2019-09-06 | 2019-09-06 | |
| US62/896,980 | 2019-09-06 | ||
| US201962910720P | 2019-10-04 | 2019-10-04 | |
| US62/910,720 | 2019-10-04 | ||
| US201962940104P | 2019-11-25 | 2019-11-25 | |
| US62/940,104 | 2019-11-25 | ||
| PCT/US2020/049266 WO2021046265A1 (en) | 2019-09-06 | 2020-09-03 | Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546597A JP2022546597A (ja) | 2022-11-04 |
| JP2022546597A5 true JP2022546597A5 (cg-RX-API-DMAC7.html) | 2023-09-11 |
| JP7700101B2 JP7700101B2 (ja) | 2025-06-30 |
Family
ID=74853052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514708A Active JP7700101B2 (ja) | 2019-09-06 | 2020-09-03 | 閉端dnaおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220280427A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4025196A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7700101B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114929205B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020342668B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3150452A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291038A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021046265A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021060440A1 (ja) * | 2019-09-26 | 2021-04-01 | 日油株式会社 | 脂質ナノ粒子の凍結乾燥組成物 |
| US12534435B2 (en) | 2020-03-27 | 2026-01-27 | Generation Bio Co. | Lipids and nanoparticle compositions thereof |
| CN115968280A (zh) * | 2020-05-18 | 2023-04-14 | 世代生物公司 | 新型脂质及其纳米颗粒组合物 |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
| MX2023001109A (es) | 2020-07-27 | 2023-04-24 | Anjarium Biosciences Ag | Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas. |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| WO2022261101A1 (en) * | 2021-06-07 | 2022-12-15 | Generation Bio Co. | Apoe and apob modified lipid nanoparticle compositions and uses thereof |
| CN117642380A (zh) * | 2021-06-14 | 2024-03-01 | 世代生物公司 | 阳离子脂质及其组合物 |
| WO2022271780A1 (en) * | 2021-06-22 | 2022-12-29 | Intellia Therapeutics, Inc. | Methods for in vivo editing of a liver gene |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| US12251471B2 (en) * | 2021-07-26 | 2025-03-18 | Oregon State University | Inhalable therapeutics |
| CN118251212A (zh) * | 2021-09-30 | 2024-06-25 | 日油株式会社 | 用于将核酸递送至淋巴管内皮细胞的脂质纳米颗粒 |
| CN114432502B (zh) * | 2021-12-31 | 2023-02-03 | 中山大学附属第八医院(深圳福田) | 一种负载op3-4多肽、抗cxcl9抗体的水凝胶及其制备方法与应用 |
| WO2023190175A1 (ja) * | 2022-03-28 | 2023-10-05 | 日油株式会社 | 末梢血単核細胞へ核酸を送達するための脂質ナノ粒子およびこれを用いて末梢血単核細胞へ核酸を送達する方法 |
| JPWO2023190176A1 (cg-RX-API-DMAC7.html) * | 2022-03-28 | 2023-10-05 | ||
| WO2023230587A2 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| WO2024112943A1 (en) * | 2022-11-22 | 2024-05-30 | University Of Maryland, Baltimore | Activated nanotherapy for sickle cell disease |
| WO2024140893A1 (zh) | 2022-12-29 | 2024-07-04 | 辽宁键凯科技有限公司 | 一种类固醇-阳离子脂质化合物及其应用 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025188836A1 (en) * | 2024-03-05 | 2025-09-12 | Saliogen Therapeutics, Inc. | Compositions and methods of using gene coding for treating ocular disease |
| WO2025213135A1 (en) * | 2024-04-04 | 2025-10-09 | The Brigham And Women's Hospital, Inc. | Lipid nanoparticles for the treatment of vascular diseases |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| CA2289702C (en) | 1997-05-14 | 2008-02-19 | Inex Pharmaceuticals Corp. | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| US6320017B1 (en) | 1997-12-23 | 2001-11-20 | Inex Pharmaceuticals Corp. | Polyamide oligomers |
| AU6814901A (en) | 2000-06-01 | 2001-12-11 | Univ North Carolina | Methods and compounds for controlled release of recombinant parvovirus vectors |
| WO2002087541A1 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Lipid-based formulations for gene transfer |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| EP1604022A2 (en) | 2003-03-06 | 2005-12-14 | Oligo Engine, Inc. | Modulation of gene expression using dna-rna hybrids |
| US20050148531A1 (en) | 2003-05-15 | 2005-07-07 | Todd Hauser | Modulation of gene expression using DNA-DNA hybrids |
| CN1882693B (zh) | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| CA3144493A1 (en) | 2006-10-03 | 2008-04-10 | Arbutus Biopharma Corporation | Lipid containing formulations |
| WO2008103276A2 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP2310440A4 (en) | 2008-07-10 | 2013-06-05 | Serina Therapeutics Inc | POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| EP3391877A1 (en) | 2010-04-08 | 2018-10-24 | The Trustees of Princeton University | Preparation of lipid nanoparticles |
| WO2011139911A2 (en) | 2010-04-29 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
| US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US20120225129A1 (en) | 2010-08-20 | 2012-09-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| ES2987915T3 (es) | 2010-09-20 | 2024-11-18 | Sirna Therapeutics Inc | Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| EP4074693A1 (en) * | 2011-06-08 | 2022-10-19 | Translate Bio, Inc. | Cleavable lipids |
| CA2853689C (en) | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| WO2013073480A1 (ja) * | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| HK1206644A1 (en) * | 2012-03-29 | 2016-01-15 | Shire Human Genetic Therapies, Inc. | Lipid-derived neutral nanoparticles |
| CN110003066B (zh) | 2013-11-18 | 2021-09-03 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2016079197A1 (en) * | 2014-11-18 | 2016-05-26 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Delivery enhancers for conjugated sirna and lipid nanoparticles |
| JP6640750B2 (ja) * | 2015-01-30 | 2020-02-05 | 日油株式会社 | カチオン性脂質 |
| HUE067372T2 (hu) | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| DK3386484T3 (da) | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| EP3315125A1 (en) * | 2016-10-31 | 2018-05-02 | Silence Therapeutics (London) Ltd | Lipid nanoparticle formulation |
| WO2018237369A2 (en) * | 2017-06-23 | 2018-12-27 | Vical Incorporated | Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection |
| CA3075168A1 (en) * | 2017-09-08 | 2019-03-14 | Generation Bio Co. | Modified closed-ended dna (cedna) |
| EP3679148A4 (en) * | 2017-09-08 | 2021-06-09 | Generation Bio Co. | LIPID NANOPARTICLE FORMULATIONS FROM NONVIRAL, CAPSID-FREE DNA VECTORS |
| AU2019221642A1 (en) * | 2018-02-14 | 2020-07-09 | Generation Bio Co. | Non-viral DNA vectors and uses thereof for antibody and fusion protein production |
| CA3094057C (en) * | 2018-03-27 | 2025-04-08 | Nof Corporation | CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS |
-
2020
- 2020-09-03 CN CN202080076963.3A patent/CN114929205B/zh active Active
- 2020-09-03 WO PCT/US2020/049266 patent/WO2021046265A1/en not_active Ceased
- 2020-09-03 US US17/632,262 patent/US20220280427A1/en not_active Abandoned
- 2020-09-03 CA CA3150452A patent/CA3150452A1/en active Pending
- 2020-09-03 AU AU2020342668A patent/AU2020342668B2/en active Active
- 2020-09-03 EP EP20860233.4A patent/EP4025196A4/en active Pending
- 2020-09-03 JP JP2022514708A patent/JP7700101B2/ja active Active
-
2022
- 2022-03-01 IL IL291038A patent/IL291038A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502576A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518985A5 (cg-RX-API-DMAC7.html) | ||
| JP2023534043A5 (cg-RX-API-DMAC7.html) | ||
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| JP2024517644A5 (cg-RX-API-DMAC7.html) | ||
| AU2020342668B2 (en) | Lipid nanoparticle compositions comprising closed-ended DNA and cleavable lipids and methods of use thereof | |
| JP2024522692A5 (cg-RX-API-DMAC7.html) | ||
| US20230320993A1 (en) | Methods for encapsulating polynucleotides into reduced sizes of lipid nanoparticles and novel formulation thereof | |
| JP2023527747A5 (cg-RX-API-DMAC7.html) | ||
| US20240293574A1 (en) | Cationic lipids and compositions thereof | |
| US20250249123A1 (en) | Lipids and compositions thereof | |
| JP2024520756A5 (cg-RX-API-DMAC7.html) | ||
| JP2024529343A5 (cg-RX-API-DMAC7.html) | ||
| US20230181764A1 (en) | Novel lipids and nanoparticle compositions thereof | |
| RU2023129760A (ru) | Катионные липиды и их композиции | |
| RU2023135629A (ru) | Катионные липиды и их композиции |